US 8883448
Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes
granted A61KA61K39/00A61K40/11
Quick answer
US patent 8883448 (Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K39/00, A61K40/11, A61K40/4253, A61P